Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors

Molecular Pharmacology

Volumn 50, Issue 1, 1996, Pages 104-111

  Bhattacharya, Samita ^a   Linden, Joel ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; THEOPHYLLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; LIGAND BINDING; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DOWN REGULATION;

ADENOSINE; ALLOSTERIC REGULATION; ANIMALS; CHO CELLS; CRICETINAE; CYCLIC AMP; DOWN-REGULATION; HUMANS; KINETICS; RADIOLIGAND ASSAY; RECEPTORS, PURINERGIC P1; RECOMBINANT PROTEINS; THIOPHENES; TRANSFECTION;

EID: 0029895280     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Tucker, A. L., and J. Linden. Cloned receptors and cardiovascular responses to adenosine. Cardiovasc. Res. 27:62-67 (1993).
2. Linden, J., M. A. Jacobson, C. Hutchins, and M. Williams. Adenosine receptors, in Handbook of Receptors and Channels: G Protein Coupled Receptors (S. J. Peroutka, ed.). CRC Press, Boca Raton, FL, 29-44 (1994).
3. Linden, J. Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions (Review). Trends Pharmacol. Sci. 15:298-306 (1994).
4. 1 receptor binding and function by 2-amino-3-benzoylthiophenes. Mol. Pharmacol. 38:939-949 (1990).
5. Kollias-Baker, C., J. Ruble, D. Dennis, R. F. Bruns, J, Linden, and L. Belardinelli. Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine. Circ. Res. 75:961-971 (1994).
6. 1 adenosine receptor coupling to G proteins. Biochim. Biophys. Acta Mol. Cell Res. 1265:15-21 (1995).
7. Janusz, C. A., and R. F. Berman. The adenosine binding enhancer, PD 81,723, inhibits epileptiform bursting in the hippocampal brain slice. Brain Res. 619:131-136 (1993).
8. Mudumbi, R. V., S. C. Montamat, R. F. Bruns, and R. E. Vestal. Cardiac functional responses to adenosine by PD 81:723, an allosteric enhancer of the adenosine A1 receptor. Am. J. Physiol. 264:H1017-H1022 (1993).
9. 1 adenosine receptor enhancer of the negative dromotropic action of adenosine in the guinea pig heart. J. Pharmacol. Exp. Ther. 266:611-617 (1993).
10. Mizumura, T., J. A. Auchampach, J. Linden, R. F. Bruns, and G. J. Gross. PD 81:723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Circ. Res., in press.
11. ATP channels, and ischemic preconditioning in dogs. Am. J. Physiol. 264:H1327-H1336 (1993).
12. Parrratt, J. R. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol. Sci. 15:19-25 (1994).
13. 1 adenosine receptor. FASEB J. 5:2668-2676 (1991).
14. 1-receptors, guanine nucleotide and forskolin binding sites following transient brain ischemia: a quantitative autoradiographic study. Brain Res. 491:212-226 (1989).
15. 1 agonist in rat hippocampal cells. Neurosurgery 36:1003-1008 (1995).
16. 1 adenosine receptor-mediated inhibition of cardiac myocyte contractility and adenylate cyclase activity: relation to the regulation of receptor affinity and density. Circ. Res. 67:406-414 (1990).
17. 1 MF-2 cells. Mol. Pharmacol 40:639-647 (1991).
18. Shryock, J., A. Patel, L. Belardinelli, and J. Linden. Downregulation and desensitization of A1-adenosine receptors in embryonic chicken heart. Am. J. Physiol. 256:H321-H327 (1989).
19. Lee, H. T., C. I. Thompson, A. Hernandez, J. L. Lewy, and F. L. Belloni. Cardiac desensitization to adenosine analogues after prolonged R-PIA infusion in vivo. Am. J. Physiol. 265:H1916-H1927 (1993).
20. 125I]Aminobenzyladenosine, a new radioligand with improved specific binding to adenosine receptors in heart. Circ. Res. 56:279-284 (1985).
21. 2A adenosine receptors with hexahistidine and the FLAG epitope: development of an efficient generic protein purification procedure. Biochem. Pharmacol., in press.
22. Stowell, C. P., T. G. Kuhlenschmidt, and C. A. Hoppe. A fluorescamine assay for submicrogram quantities of protein in the presence of Triton X-100. Anal. Biochem. 85:572-580 (1978).
23. Marquardt, D. M. An algorithm for least-squares estimation of nonlinear parameters. J. Soc. Ind. Appl. Math. 11:431-441 (1963).
24. Tabata, T., and R. Ito. Effective treatment of the interpolation factor in Marquardt's nonlinear least-squares fit algorithm. Comput. J. 18:250-251 (1975).
25. Motulsky, H. J., and L. A. Ransnas. Fitting curves to data using nonlinear regression: a practical and nonmathematical review (Review). FASEB J. 1:365-374 (1987).
26. 1 receptor binding and function, in Adenosine Receptors in the Nervous System (J. A. Ribeiro, ed.). Taylor & Francis, London, 53-60 (1989).
27. Yeung, S. H., and R. D. Green. Agonist and antagonist affinities for inhibitory adenosine receptors are reciprocally affected by 5′-guanylylimidodiphosphate or N-ethylmaleimide. J. Biol. Chem. 258:2334-2339 (1983).
28. Barker, J. L., N. L. Harrison, and A. P. Mariani. Benzodiazepine pharmacology of cultured mammalian CNS neurons. Life Sci. 39:1959-1968 (1986).
29. Monod, J., J.-P. Changeux, and F. Jacob. Allosteric proteins and cellular control systems. J. Mol. Biol. 6:306-329 (1963).
30. Lefkowitz, R. J. G protein-coupled receptor kinases (Review). Cell 74:409-412 (1993).
31. Kameyama, K., K. Haga, T. Haga, K. Kontani, T. Katada, and Y. Fukada. Activation by G protein beta gamma subunits of beta-adrenergic and muscarinìc receptor kinase. J. Biol. Chem. 268:7753-7758 (1993).